Related Experiment Video
Updated: Mar 21, 2026
10:02
Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs
Published on: July 23, 2016
33.6K
Fine-Needle Diathermy with Simultaneous Subconjunctival Bevacizumab
Rumana Hussain1, Vijay Savant1
1a Leicester Royal Infirmary , Leicester , UK.
Seminars in Ophthalmology
|May 19, 2016
Summary
Subconjunctival bevacizumab combined with fine-needle diathermy effectively treats corneal vascularization, especially in cases with lipid deposition. However, managing ongoing inflammatory conditions presents greater challenges.
Area of Science:
- Ophthalmology
- Corneal Disease Treatment
Background:
- Corneal vascularization poses a significant challenge in ophthalmology.
- Effective treatment strategies are crucial for preserving vision.
Purpose of the Study:
- To evaluate the efficacy of subconjunctival bevacizumab and fine-needle diathermy for corneal vascularization.
- To assess outcomes in patients with and without lipid deposition.
Main Methods:
- Retrospective analysis of patient cases treated between 2010 and 2013.
- Treatment involved subconjunctival bevacizumab and fine-needle diathermy.
Main Results:
- Good outcomes were observed in patients with corneal lipid deposition.
- 3 out of 5 patients required multiple treatment sessions.
- One patient with severe atopy and failed grafts required extensive treatment.
Conclusions:
- Concurrent use of subconjunctival bevacizumab and fine-needle diathermy is effective for lipid deposition-related corneal vascularization.
- Managing corneal vascularization in the presence of inflammation is more complex.
